Controlling the Cost Spent on Expensive Biologic Agents- an Example of Net Monetary Savings By Dose Optimisation of Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis Patients
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.2324
https://www.valueinhealthjournal.com/article/S1098-3015(15)04400-9/fulltext
Title :
Controlling the Cost Spent on Expensive Biologic Agents- an Example of Net Monetary Savings By Dose Optimisation of Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis Patients
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)04400-9&doi=10.1016/j.jval.2015.09.2324
First page :
A647
Section Title :
Research Podium Presentations - Session 1 and Session 2
Open access? :
No
Section Order :
1731